Oklahoma 2024 2024 Regular Session

Oklahoma Senate Bill SB1264 Engrossed / Bill

Filed 03/18/2024

                     
 
ENGR. S. B. NO. 1264 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
ENGROSSED SENATE 
BILL NO. 1264 	By: Stanley of the Senate 
 
  and 
 
  Miller of the House 
 
 
 
 
[ health insurance - coverage - exclusions - 
codification - effective date ] 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.    NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 6060.5b of Title 36, unless 
there is created a duplication in numbering, reads as follows: 
A.  For the purposes of this section: 
1.  “Clinical utility” means clinical utility as defined 
pursuant to Section 6060.5a of Title 36 of the Oklahoma Statutes; 
2.  “Evidence-based cancer imaging ” means appropriate 
preventative screening and imagi ng supported by evidence; 
3.  “Genetic testing for an inherited mutation ” means multi-gene 
testing for an inherited mutation associated with an increased risk 
of cancer; 
4.  “Health benefit plan” means a health benefit plan as defined 
pursuant to Section 6060.4 of Title 36 of the Oklahoma Statutes; and   
 
ENGR. S. B. NO. 1264 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
5.  “Health care provider ” means any physician, hospital, or 
other entity or person that is licensed or otherwise authorized in 
this state to furnish health care services. 
B.  Any health benefit plan includin g the Oklahoma Employees 
Insurance Plan that is offered, issued, or renewed in this stat e on 
or after the effective date of this act shall provide coverage for: 
1.  Clinical genetic testing for an inherited gene mutation for 
individuals with a personal or family history of cancer when such 
test provides clinical utility and when ordered or re commended by a 
health care provider in accordance with medical and scientific 
evidence including, but not limited to: 
a. the most recent version of the National Compreh ensive 
Cancer Network (NCCN) clinical practice 
recommendations that are level 2a or high er, 
b. Centers for Medicare and Medicaid Services national 
coverage determinations or Medicare administrative 
contractor local coverage determinations, and 
c. nationally recognized clinical practice guidelines; 
and 
2.  Evidence-based cancer imaging for ind ividuals with an 
increased risk of cancer when such test provides clinical utility 
and when ordered or recommended by a health care provider in 
accordance with the most recent version of the NCCN clinical 
practice recommendations that are level 2a or highe r, or in   
 
ENGR. S. B. NO. 1264 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
accordance with other nationally recognized clinical practice 
guidelines. 
C.  Coverage under this section shall not be subject to any 
annual deductibles, copayments, or coinsurance limits as established 
for all covered benefits under the health be nefit plan. 
D.  If application of this section would result in health 
savings account ineligibility under Section 223 of the federal 
Internal Revenue Code, as amended, the provisions of this section 
shall only apply to health savings accounts with qualifie d high 
deductible health plans with respect to the deductible of such a 
plan after the enrollee has satisfied the minimum deductible.  
Provided, however, the provisions of this section shall apply to 
items or services that are preventive care pursuant to S ection 
223(c)(2)(C) of the federal Internal Revenue Code, as amended, 
regardless of whether the minimum deductible has been satisfied. 
SECTION 2.  This act shall become effective November 1, 2024.   
 
ENGR. S. B. NO. 1264 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Passed the Senate the 14th day of March, 2024. 
 
 
  
 	Presiding Officer of the Senate 
 
 
Passed the House of Representatives the ____ day of __________, 
2024. 
 
 
  
 	Presiding Officer of the House 
 	of Representatives